Model: Risk Parity

Performance 2/21/20 - 6/27/22
logo
Investment Approach
Risk Parity is a conservative, long only strategy that follows a risk parity (RP) approach known to be used by Bridgewater's All Weather Fund, Ray Dalio's flagship product.

The strategy invests in a group of uncorrelated liquid Exchange Traded Funds (ETFs), each representing 100s of individual assets sharing a common underlying theme or characteristics. Neuravest utilizes its portfolio optimization technology to reallocate Net Asset Value (NAV or cash value ) amongst its constituents based on recent volatility, momentum, and covariance.

Performance Versus Benchmark (RPAR Risk Parity Total Return) 2/21/20 to 6/27/22
Strategy Overall Bench Overall Strategy YTD Bench YTD
Abs. Return 1.8% -1.0% -30.1% -19.5%
Rel. Return 2.9% N/A -10.6% N/A
Beta 0.83 N/A 0.57 N/A
Ann. Volatility 18.6% 13.3% 17.8% 14.9%
Sharpe 0.62 0.04 -1.61 -2.86
Drawdown -34.3% -22.2% -34.3% -20.8%
IR 0.73 N/A 0.82 N/A
Tracking Error 15.1% N/A 17.0% N/A
Historical Summary
1 Yr 2 Yr 3 Yr 5 Yr 10 Yr
Ann. Return -24.0% -1.6% 0.8% N/A N/A
Ann. Volatility 14.8% 15.0% 18.6% N/A N/A
Performance Attribution
Risk/Return versus benchmark
Monthly Return Comparison Trailing 12 Months
Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Total
Strategy 5.2% 2.2% -6.1% 5.3% -1.5% 3.8% -10.4% -4.2% 1.1% -10.5% -4.4% -5.9% -24.0%
Benchmark 2.4% 0.2% -3.2% 3.7% 0.1% 1.2% -3.9% -0.0% -1.3% -8.4% -1.8% -5.6% -16.0%
Rel. Return 2.8% 2.0% -2.9% 1.6% -1.6% 2.6% -6.5% -4.1% 2.3% -2.1% -2.5% -0.3% -8.0%
Perspective on Performance
Although the portfolio is leveraged 2X, it still exhibits lower volatility than the SP500 and over time outperforms it handsomely in total returns and Sharpe ratio.
  
Model: Risk Parity

Model: Risk Parity

Strategy Performance Analysis by Neuravest
logo
Performance Report
Performance Chart
Correlation
Beta
Exposure
  
Performance Metrics
Portfolio Initial Adjusted Final Adjusted Return Compound Annual Return
Model: Risk Parity$977,958$995,720$17,762 0.8%
RPAR Risk Parity$20.01$19.80($0.21) -0.6%
Portfolio Return Sharpe Sortino Ann. Volatility Max Drawdown
Model: Risk Parity1.8%0.620.83 18.6% 34.3%
RPAR Risk Parity-1.0%0.040.05 13.3% 22.2%

Transaction Cost:
Number of Transactions1,289
Total Commissions ($0.0035 per share, $2.95 min per trade)$2,733
Slippage$97
Borrowing CostsN/A
Total Transaction Costs$2,830

Professional Fees:
Management Fee (0.4%)$5,563
Performance Fee (Hurdle 8.0% / Performance 10.0%) $15,468
Total Professional Fees$21,031
Benchmark Relative Metrics:
Beta0.83
Information Ratio0.73
Annualized Tracking Error15.1%

Trade Analysis
Trade Metrics (Successful):
Metric Long Short All
# Trades 524 (49.1%) 0 (N/A) 524 (49.1%)
Avg Gain 17.23% 0.00% 17.23%
Avg Hold Time 8 months less than a second 8 months
Trade Metrics (Unsuccessful):
Metric Long Short All
# Trades 543 (50.9%) 0 (N/A) 543 (50.9%)
Avg Loss -4.01% 0.00% -4.01%
Avg Hold Time 4 months less than a second 4 months

Best Long Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
MTUM Mar 26, 2020 9:31:20 AM Aug 6, 2020 9:30:22 AM 4 months 44.6% $81,733.65 9.3%

Worst Long Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl
TLT Mar 3, 2022 9:30:01 AM May 6, 2022 9:33:21 AM 2 months -16.8% ($65,192.97) -5.3%

Best Short Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl

Worst Short Trade:
Ticker Open Date Close Date Hold Time Pnl Amount Weighted Pnl

Performance Metrics By Year
2020 2021 2022
ReturnStrategy 24.0% 17.5% -30.1%
RPAR Risk Parity 14.3% 7.6% -19.5%
Winning DaysStrategy 56.2% 56.3% 28.1%
RPAR Risk Parity 56.6% 54.0% 44.6%
SharpeStrategy 1.17 1.32 -1.61
RPAR Risk Parity 1.02 0.85 -2.86
SortinoStrategy 1.63 1.83 -2.03
RPAR Risk Parity 1.10 1.22 -3.79
Max DDStrategy 18.5% 10.1% 34.3%
RPAR Risk Parity 19.8% 6.4% 20.8%
Ann. VolatilityStrategy 23.8% 12.8% 17.8%
RPAR Risk Parity 16.0% 9.1% 14.9%
  

Monthly Return to Benchmark By Year
JanFebMarAprMayJunJulAugSepOctNovDecTotal
2020 Strategy 0.0% -4.2% -8.4% 12.4% 4.0% 4.0% 9.2% 3.4% -3.3% -4.4% 8.9% 2.1% 24.0%
Benchmark 0.0% -2.7% -5.9% 5.6% 2.1% 2.2% 6.3% 0.6% -1.8% -2.3% 6.1% 3.8% 14.3%
Relative Return 0.0% -1.5% -2.4% 6.8% 1.9% 1.8% 2.9% 2.8% -1.5% -2.1% 2.8% -1.7% 9.7%
 
2021 Strategy -2.0% -2.9% 1.6% 7.0% 0.5% 4.0% 5.2% 2.2% -6.1% 5.3% -1.5% 3.8% 17.5%
Benchmark -1.2% -1.8% -1.4% 2.9% 3.0% 1.8% 2.4% 0.2% -3.2% 3.7% 0.1% 1.2% 7.6%
Relative Return -0.8% -1.1% 3.0% 4.1% -2.5% 2.2% 2.8% 2.0% -2.9% 1.6% -1.6% 2.6% 9.9%
 
2022 Strategy -10.4% -4.2% 1.1% -10.5% -4.4% -5.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -30.1%
Benchmark -3.9% -0.0% -1.3% -8.4% -1.8% -5.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -19.5%
Relative Return -6.5% -4.1% 2.3% -2.1% -2.5% -0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -10.6%
 
Monthly Turnover By Year
JanFebMarAprMayJunJulAugSepOctNovDecTotal
2020 N/A 245.6% 293.5% 22.5% 2.3% 5.9% 21.2% 17.9% 24.3% 9.3% 10.2% 4.1% 656.9%
2021 17.5% 46.7% 67.7% 6.3% 6.9% 19.4% 53.5% 23.2% 71.4% 112.4% 55.1% 109.6% 589.6%
2022 236.2% 198.1% 168.2% 149.9% 200.1% 175.3% N/A N/A N/A N/A N/A N/A 1,127.8%
  

FOR QUALIFIED INSTITUTIONAL INVESTOR USE ONLY. NOT INTENDED FOR INDIVIDUAL RETAIL INVESTORS.

Investment advisory services provided by Neuravest Research Inc., a registered investment adviser. Registration as an investment adviser does not imply a certain level of skill or training. Nothing presented herein has been approved or verified by the United States Securities and Exchange Commission or by any self regulatory organization (SRO), or state securities authority.

Information presented herein is hypothetical and solely for informational purposes only, and should not be construed as an offer to buy or a solicitation of an offer to sell any security or other investment product. Though we have endeavored to present the information contained herein from sources believed to be reliable, we cannot guarantee the accuracy of such information and make no warranties or representations as such.

All investments involve risks that an investor should fully understand and be willing to bear. Past performance is no guarantee of future returns, and investing can result in partial or complete loss of invested capital. Such risks can be magnified to the extent leverage is deployed in the pursuit of potentially higher returns.

To the extent investment returns are presented, such investment returns are either hypothetically backtested or reflect a perpetual paper trading simulation and are labeled as such. Returns are presented as net returns of transaction costs, slippage and short borrowing costs (when applicable). Investment returns are also net of Neuravest standard annualized management fees of 40 basis points (on Assets Under Management) and 10% performance fee on excess return above an 8% hurdle. Investment returns presented reflect the reinvestment of dividends and other earnings, however they do not account for taxes that an investor may owe as a result of any investment gains. Investors may incur taxes as a result of investing, and may pay different transaction costs to the ones presented to the broker-dealer executing the transactions for their account(s).

Hypothetical backtested returns are simulated, retroactive, and created using the benefit of hindsight to a select period of time, and are thus inherently not as reflective of actual historical returns. Any hypothetical backtested returns are based on the following assumptions and criteria:

  • Actual price was available for execution
  • Capacity and daily float was supportive of volume traded.
  • Transaction cost and slippage are reflective of real-world brokerage fees.

Hypothetical backtested returns do not reflect actual trading and do not reflect the impact that material economic and market factors may have had on Neuravest’s algorithmic decision-making at the time.

To the extent investment performance is compared to one or more indexes, investors should be aware that one cannot invest directly into an index (a simulated basket of securities that do not reflect fees, costs, or taxes that an investor may actually incur).

Neuravest Research and its affiliates do not provide tax, legal or accounting advice. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. You should consult your personal tax, legal and accounting advisors before engaging in any transaction.

Asset allocation/diversification or hedging does not guarantee a profit or protect against a loss.

Hypothetical perpetual paper trading simulation results, past performance is not indicative of future returns. Results are net of transactions' cost and net of annualized management fees of 40 basis points as well as net of performance fee of 10% on any return in excess of an 8% hurdle. Results are provided as informational and could potentially include misleading and hypothetical information. If you are a retail investor this information is NOT intended for you. Results are meant as information only for qualified institutional investors only. If you are looking to engage Neuravest in any of the product offerings, the minimum investment size requirement is $1 million USD.

Performance fees may vary depending upon executed leverage.

NEURAVEST RESEARCH INC (CRD# 312803/SEC#: 801-120607)